<DOC>
	<DOCNO>NCT02868385</DOCNO>
	<brief_summary>An open label , randomize control trial single vs. multiple treatment praziquantel intestinal African schistosomiasis Côte d'Ivoire This study aim determine efficacy repeat ( four time ) praziquantel treatment S. mansoni infection school-age child Côte d'Ivoire use traditional Kato-Katz thick smear technique , also accurate non-invasive antigen- DNA-detection method .</brief_summary>
	<brief_title>Repeated Doses Praziquantel Schistosomiasis Treatment ( RePST )</brief_title>
	<detailed_description />
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Subject confirm S. mansoni infection ( positive POCCCA test result least one positive triplicate KatoKatz thick smear ) Subject age 5 18 year otherwise good health Subject receive recent praziquantel treatment past 12 month Subject provide oral assent provide write informed consent sign parents/legal guardian Subject able willing provide multiple stool urine sample study Known allergy study medication ( i.e . praziquantel albendazole ) Pregnancy Lactating</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Schistosomiasis</keyword>
	<keyword>Schistosoma mansoni</keyword>
	<keyword>Bilharzia</keyword>
</DOC>